Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Animal drug company Eco Animal Health said it had received a positive opinion from the European Medicines Agency for the use of Aivlosin water-soluble granules for the treatment of Mycoplasma hyopneumoniae in pigs.
Mycoplasma hyopneumoniae was the most common primary pathogen in pig respiratory disease and a key instigator of secondary bacterial and viral pathogens.
Aivlosin, an antimicrobial, was used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric diseases in poultry and pigs.
The European Commission as expected to issue a marketing authorisation within two months of the publication of a positive opinion, the company said.
At 1:27pm: (LON:EAH) Eco Animal Health Group PLC share price was +10.5p at 208p